Elicio Therapeutics (ELTX) CEO awarded 186,944 stock options at 3.2000
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Elicio Therapeutics, Inc. granted CEO, President and Director Robert Connelly a stock option for 186,944 shares of common stock at an exercise price of 3.2000 per share on July 16, 2026, expiring July 16, 2036. The option vests 50% on July 16, 2027 and 50% on July 16, 2028, subject to his continued service, resulting in direct holdings of 186,944 options under this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Connelly Robert
Role
CEO, President and Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 186,944 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 186,944 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option shares granted: 186944.0000 shares
Exercise price: 3.2000 per share
Option expiration date: 2036-07-16
+2 more
5 metrics
Option shares granted
186944.0000 shares
Stock option award to CEO Robert Connelly on July 16, 2026
Exercise price
3.2000 per share
Exercise price of the granted stock option
Option expiration date
2036-07-16
Expiration of the stock option grant
First vesting tranche
50% of options
Vests on July 16, 2027, subject to continued service
Second vesting tranche
50% of options
Vests on July 16, 2028, subject to continued service
Key Terms
Stock Option (Right to Buy), vesting, exercise price, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
vesting financial
"The stock option vests and becomes exercisable as to 50% of the options"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: 3.2000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-16"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Elicio Therapeutics (ELTX) report for Robert Connelly?
Elicio Therapeutics reported that CEO, President and Director Robert Connelly received a stock option grant for 186,944 shares of common stock at an exercise price of 3.2000 per share, with an expiration date of July 16, 2036 and time-based vesting conditions.
How many options were granted to the ELTX CEO and at what exercise price?
Robert Connelly received 186,944 stock options, each with an exercise price of 3.2000 per share. These options relate to Elicio Therapeutics common stock and were awarded as a compensation grant on July 16, 2026, subject to a multi-year vesting schedule.
What is the vesting schedule of the new ELTX stock options granted to the CEO?
The stock option vests in two equal tranches: 50% on July 16, 2027 and 50% on July 16, 2028. Vesting is conditioned on Robert Connelly’s continued service with Elicio Therapeutics through each respective vesting date.
When do the CEO’s newly granted ELTX stock options expire?
The granted stock options expire on July 16, 2036. After this date, any unexercised portion of the 186,944-share option award will no longer be exercisable, consistent with the long-term term commonly used in executive stock option grants.
How many ELTX options does Robert Connelly hold after this grant?
Following this award, Robert Connelly holds 186,944 stock options reported as directly owned under this specific grant. This reflects the full size of the new option award, subject to its stated vesting schedule and expiration terms.